Premium
Enstilar cutaneous foam for the treatment of psoriasis vulgaris
Author(s) -
Chaplin Steve
Publication year - 2016
Publication title -
prescriber
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.106
H-Index - 3
eISSN - 1931-2253
pISSN - 0959-6682
DOI - 10.1002/psb.1517
Subject(s) - medicine , calcipotriol , psoriasis , dermatology , betamethasone , plaque psoriasis , adverse effect , betamethasone dipropionate
Enstilar (calcipotriol and betamethasone) is a new cutaneous foam formulation recently launched for the treatment of psoriasis vulgaris (plaque psoriasis) in adults. This article discusses its place in therapy, efficacy and adverse effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom